Response by Essayagh et al to Letter Regarding Article, "The MIDA-Q Mortality Risk Score: A Quantitative Prognostic Tool for the Mitral Valve Prolapse Spectrum"
Circulation
.
2023 Sep 19;148(12):980-981.
doi: 10.1161/CIRCULATIONAHA.123.065630.
Epub 2023 Sep 18.
Authors
Benjamin Essayagh
1
2
,
Giovanni Benfari
1
,
Clemence Antoine
1
,
Francesco Grigioni
3
,
Thierry Le Tourneau
,
Jean-Christian Roussel
4
,
Jeroen J Bax
5
,
Nina Ajmone Marsan
5
,
Aniek van Wijngaarden
5
,
Christophe Tribouilloy
6
,
Dan Rusinaru
6
,
Aviram Hochstadt
7
,
Yan Topilsky
8
,
Prabin Thapa
1
,
Hector I Michelena
1
,
Maurice Enriquez-Sarano
1
Affiliations
1
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN (B.E., G.B., C.A., P.T., H.I.M., M.E.-S.).
2
Division of Echocardiography, Cardio X Clinic, Cannes, France (B.E.).
3
Department of Cardiology, University Campus Bio-Medico, Rome, Italy (F.G.).
4
Department of Cardiology, University of Nantes, France (T.L.N., J.-C.R.).
5
Department of Cardiology, Leiden University Medical Center, he Netherlands (J.J.B., N.A.M., A.v.W.).
6
Department of Cardiology, University of Amiens, France (C.T., D.R.).
7
Heart Institute, Wolfson Medical Center and the Sackler Faculty of Medicine, Tel-Aviv University, Israel (A.H.).
8
Department of Cardiology, Tel Aviv Medical Center and Sackler Faculty of Medicine, Israel (Y.T.).
PMID:
37721975
DOI:
10.1161/CIRCULATIONAHA.123.065630
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Humans
Mitral Valve Prolapse*
Prognosis